Evidence map›Paper›PMID 36406439›Full record

ArticleFrontiers in microbiology2022

Fouzia Idir, Sybren Van Ginneken, Guglielmo A Coppola, Daniel Grenier, Hans P Steenackers, Farida Bendali

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Aqueous extracts ofBiofilm · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Effects ofIn vivo (Athens, Greece)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Fouzia IdirLaboratoire de Microbiologie Appliquée, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia, Algeria.
Sybren Van GinnekenMiCA Lab, Centre of Microbial and Plant Genetics, KU Leuven, Leuven, Belgium.
Guglielmo A CoppolaMiCA Lab, Centre of Microbial and Plant Genetics, KU Leuven, Leuven, Belgium.
Daniel GrenierOral Ecology Research Group, Faculty of Dentistry, Université Laval, Quebec, QC, Canada.
Hans P SteenackersMiCA Lab, Centre of Microbial and Plant Genetics, KU Leuven, Leuven, Belgium.
Farida BendaliLaboratoire de Microbiologie Appliquée, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia, Algeria.
KU Leuven · BEUniversity of Béjaïa · DZUniversité Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dental caries and periodontal diseases remain a challenge for oral health, especially given the lack of effective and safe treatment options that are currently available. Against the backdrop of an ongoing antimicrobial resistance crisis, a renewed interest in traditional medicinal plants as a potential source of new bioactive compounds has surfaced. In this context, we systematically screened the antimicrobial and anti-biofilm activities of both ethanolic and aqueous extracts of nine Algerian medicinal plants (

Indexed as

anti-biofilm activityantimicrobial activityoral pathogenic bacteriaOriganum vulgare ethanolic extractthymol

Identifiers

PMID36406439
PMCPMC9668103
OpenAlexW4308126014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.